Sign in to view content

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials

Katherine E Talcott, MD

Video
Published 2021

Related

Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020
Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2020
Tarcocimab Tedromer (KSI-301) Anti-VEGF Antibody Biopolymer Conjugate for DME: First-Time Efficacy, Durability and Safety Results of the GLEAM and GLIMMER Phase 3 studies
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more